Yahoo Finance

New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Yahoo Finance

Teleflex Celebrates June Men’s Health Month with Launch of UroLift® Patient Ambassador Program

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Business Wire

NeoTract Announces Results from Five Real-World Studies Reaffirming Efficacy and Safety of UroLift ® System Treatment for Enlarged Prostate

Five Studies Show Significant Relief and Improved Quality of Life with UroLift System The “Real-World Experience” study, which enrolled 156 patients at the Norfolk & Norwich University Hospital in the ...
Business Wire

NeoTract Announces FDA Clearance of Expanded Indications for UroLift ® System

WAYNE, Pa.--(BUSINESS WIRE)--NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE: TFX) focused on addressing unmet needs in the field of urology, today announced that the U.S. Food and ...
irblog.prnewswire.com

NICE gives go ahead to NeoTract's groundbreaking UroLift® Prostate Implant that can preserve sexual function while offering urinary symptom relief for millions of men affected ...

PLEASANTON, Calif., Jan. 29, 2014 /PRNewswire/ -- NeoTract, Inc., today announced that the UK's National Institute for Health and Clinical Excellence (NICE) has issued an Interventional Procedure ...
Business Insider

NeoTract Designates Dr. Matt Ashley as UroLift® Center of Excellence

PLEASANTON, Calif., March 19, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
Financial Times

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over ...

WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 ...
Nasdaq

Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting

WAYNE, Pa., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the ...
Nasdaq

Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical ...

WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, announced today that a new peer-reviewed study in the Nature journal ...
Financial Times

Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with ...

First Head-to-Head Randomized Control Study (RCT) Reinforces Early Patient Experience Benefits and 12-month Durability of the UroLift™ System versus Rezūm™ 1 Three-Year Data Demonstrate Sustained ...
Stockhouse

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift(TM) System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over ...

WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 ...